PSMB9 and COVID-19: Interestingly, previous transcriptome studies have shown significantly higher expression of PSMB9 and TAP2 in individuals with COVID-19 compared to healthy control subjects, suggesting their potential involvement in excessive inflammation in individuals with COVID-19.53